How I Keep Landing Quadruple-Digit Gains

Embracing progress is the secret to building wealth. Jeff Siegel decries the naysayers and talks about why sticking to his guns with everything from electric cars to CRISPR technology has been the key to his massive profits. You are receiving this email because you subscribed to Energy and Capital. [Click here]( to manage your e-mail preferences. [Energy and Capital logo] How I Keep Landing Quadruple-Digit Gains [Jeff Siegel Photo] By [Jeff Siegel]( Written Jun. 21, 2018 If you don’t know the name Elon Musk, you’ve been living under a rock. The incredibly forward-thinking entrepreneur, who essentially forced all the major automakers to embrace electric vehicles or die, is the kind of guy who people either love or despise. He also brought reusable rockets to the mainstream and recently got early approval to build an underground transportation system that’ll take commuters from O’Hare International Airport to downtown Chicago in just 12 minutes. To put that in perspective, it would take you about an hour to make that trip by car. Take a look for yourself: Finding solutions to some of the world’s most pressing problems is something Musk does. And he does this well. But honestly, I’m not here today to praise Elon Musk. Instead, I want to shine a light on something every investor should be aware of... The "Genetic Gold Rush" Very, very soon, curing cancer will be an outpatient procedure. And it's not just cancer... Thanks to the medical "discovery of the century," over 6,000 incurable diseases will be wiped out in the blink of an eye. Scientific American predicts that this technology will spark a $6.5 trillion “Genetic Gold Rush.” According to Bloomberg, “billions of dollars in revenue” are at stake. [Here’s how to claim your share of the profits.]( Skepticism is Healthy, but Defeatism is the Enemy of Wealth What I mean by this is that those who are oftentimes quick to dismiss any kind of new technology because it seems too grand tend to be the types of people who curse those who eventually profit from it. We saw this back with the dawn of the affordable automobile. It was in 1903 when the president of the Michigan Savings Bank told Henry Ford's lawyer, Horace Rackham, “The horse is here to stay, but the automobile is only a novelty – a fad.” Fortunately, Rackham didn't listen and invested $5,000 in Ford stock. He later sold it for $12.5 million. And of course, we saw it again when Elon Musk had the audacity to launch an electric car company right before the global economy went into a tailspin. It was back in 2010 when I recommended that folks buy shares of Tesla. Despite an avalanche of hostile emails from folks telling me how stupid I was, I stuck to my guns. We bought shares for about $30 a piece. This week, Tesla hit a new high of $389.61. That’s a gain of nearly 1,200%. [tzla] But I’m not telling you about this to chest pound. I’m telling you this because it’s one of many examples of how I’ve personally embraced innovation — and profited from it — instead of mocking it. I did it with Tesla. I did it with renewable energy. I did it with cannabis. In fact, had you taken my advice to buy cannabis producer Canopy Growth Corporation (TSX: WEED) for $1.40 a few years ago, you’d now be up more than 2,440%. Take a look... A one-time $50,000 investment would be worth nearly $1.3 million today. The crazy thing, though, is that to this day, people still tell me I’m foolish to invest in cannabis. Bu you know what? I’m crying all the way to the bank. Bitcoin 2.0: The Next Generation If you had put $100 into Bitcoin in 2010, it would now be worth over $110 million! There is one little-known cryptocurrency on our radar with untold growth potential. It could hands down be bigger than Bitcoin! [Check out the exclusive report here.]( Don’t Fear Progress. Profit from It! If there’s one thing I’ve learned in my more than two decades in investment analysis, it’s that to make a lot of money, you can’t be concerned about the naysayers. The Luddites. The folks who are so scared of progress that they’d rather mock it than profit from it. What idiots! In fact, last week I told you about how, despite a recent sell-off in the market, we continue to invest in the biotech blockbuster known as CRISPR. This is the technology that has the power to end disease forever. From heart disease and cancer to diabetes and Parkinson’s disease, this CRISPR technology holds the key to eliminating most major diseases from our world — forever. And you better believe we’re getting a piece of this action. But, just as I had expected, there were plenty of people who emailed me to tell me how I’m clueless and how CRISPR technology will never amount to anything. Blah, blah, blah. I’ve heard it all before, and I’m sure I’ll continue to hear it as I focus my coverage on the types of groundbreaking industries that are setting the stage for all the things that will one day become commonplace. Look at it like this... A hundred years ago, so many people laughed when the world saw the earliest stages of personal automobiles, commercial airliners, personal computers, even the internet. Those things are now as ubiquitous as trees, mountains, and oceans. There are always plenty of investors who will give you a thousand reasons why something will never work. Those are the people who will never enjoy the kind of wealth that affords things like summer homes, first-class travel, and the ability to never have to worry about how much something costs at the grocery store. Those are the people worth ignoring. In fact, if you consider yourself one of those people, then I suggest you stop reading now, because you’re not going to like what you’re about to read. In an effort to help forward-thinking investors make a ton of money by investing in the types of things that poor people ignore and rich people embrace, I recently published two white papers you absolutely need to read now. The first is a complete analysis on that CRISPR technology I was just telling you about. It includes a complete breakdown of how the technology works and, of course, how you can profit from it while so many other investors remain in the dark. [Here’s the link.]( The second is a report I published that offers a sort of introduction to the world of cannabis investing. It lays out my entire thesis for why every investor should have some exposure to the cannabis space. It also gives you access to a list of [more than 35 cannabis stocks you can buy right now](. I don’t mean to be brash, but I’ve helped thousands of investors just like you make insane amounts of money by doing little more than investing in the innovations and new technologies that are on the cusp of greatness. To ignore these things would be beyond foolish. And to profit from them could be your ticket to financial freedom — forever. [Click here now to get started.]( To a new way of life and a new generation of wealth... [Jeff Siegel Signature] Jeff Siegel [[follow basic]@JeffSiegel on Twitter]( Jeff is the founder and managing editor of Green Chip Stocks, a private investment community that capitalizes on opportunities in alternative energy, organic food markets, legal cannabis, and socially responsible investing. He has been a featured guest on Fox, CNBC, and Bloomberg Asia, and is the author of the best-selling book, Investing in Renewable Energy: Making Money on Green Chip Stocks. For more on Jeff, go to his editor's [page](. Enjoy reading this article? [Click here]( to like it and receive similar articles to read! Browse Our Archives [You Never Hear About These Profitable Oil Stocks]( [The End of an Empire]( [In Defense of Capitalism]( [Montemori: The Dying Currency]( [Investing in CRISPR]( Related Articles [Canadian Cannabis Will Be Big, but U.S. Cannabis Will Be Bigger]( [Trump’s Suggestion for Condos in North Korea is actually a Great Idea]( [Investing in CRISPR]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Energy and Capital, please add newsletter@energyandcapital.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. [Energy and Capital](, Copyright © 2018, [Angel Publishing LLC](. All rights reserved. 111 Market Place #720 Baltimore, MD 21202. The content of this site may not be redistributed without the express written consent of Angel Publishing. Individual editorials, articles and essays appearing on this site may be republished, but only with full attribution of both the author and Energy and Capital as well as a link to www.energyandcapital.com. Your privacy is important to us -- we will never rent or sell your e-mail or personal information. Please read our [Privacy Policy](. No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. [Energy and Capital]( does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. The publisher, editors and consultants of Angel Publishing may actively trade in the investments discussed in this publication. They may have substantial positions in the securities recommended and may increase or decrease such positions without notice. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question.